Skip to content

Oniris - Oniris

by Oniris

510(k) K250353Ref ONIPLUSSPT2, ONIPLUSIO - ONIPLUSIE, ONIPLUS, ONIPLUSIET2, ONIPLUSIET1

Active European Union and United States

CE MDR 510(k)

Valid until

Not listed

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR EUDAMED Number3665389ONIRIS8X Basic UDI-DI Date20 Jan 2026RegisteredStatusActive
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK250353 Date4 Sep 2025ClearedStatusActive

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

Trade Name
Oniris Plus
Device Name
Oniris
Model / Reference
ONIPLUSSPT2, ONIPLUSIO - ONIPLUSIE, ONIPLUS, ONIPLUSIET2, ONIPLUSIET1
Primary DI / UDI-DI
03665389000286, 03665389000262, 03665389000248, 03665389000385, 03665389000378
Basic UDI-DI
3665389ONIRIS8X
510(k) Number
FDA Product Code
LRK
EMDN Code
Q03010299 Antisnoring and obstructive sleep apnoea devices - other
Models / Variants
Oniris
Device Class
Class I EUDAMED
Class II 510(k)
Regulation
21 CFR Part 872.5570
EU market of registration
France
Ireland
Bulgaria
Advisory Committee
Dental
FDA Decision
SESE Substantially Equivalent

Truth per registry

2 sources · 1 field differs

FieldEUDAMED510(k)
Device ClassEUDAMED
Class I
510(k)
Class II

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Oniris and Oniris Plus are mandibular advancement devices classified as Anti-Snoring Devices (FDA code 872.5570, Class II). These devices are designed to reposition the mandible forward to maintain an open airway during sleep, thereby reducing snoring and obstructive sleep apnea symptoms by improving pharyngeal patency.

The Oniris and Oniris Plus are single-use, non-invasive oral appliances supplied in sterile packaging. They are thermoformable and intended for home use by patients or under dental professional supervision. The Oniris Plus features enhanced bruxism resistance and progressive mandibular advancement, with a 30% greater intraoral volume than the classic model. Authorized under FDA 510K and MDR, these devices are regulated as Class II medical devices under the Dental specialty category.

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are the Oniris and Oniris Plus devices reusable or designed for single-use only? Why does this matter for patients or clinicians?

    The Oniris and Oniris Plus are explicitly designed for single-use only. This is important because single-use devices reduce the risk of cross-contamination and infection, ensuring hygiene and safety for each patient. Since they are thermoformable and intended for home use or dental professional supervision, they are not meant to be reused, even after cleaning or sterilization.

  • What key differences exist between the Oniris and Oniris Plus models, particularly in terms of functionality and patient comfort?

    The Oniris Plus features two key enhancements over the classic Oniris: enhanced bruxism resistance (better suited for patients who grind their teeth) and 30% greater intraoral volume, which may provide a more comfortable fit and potentially better airway support. The classic Oniris is designed for general snoring and mild obstructive sleep apnea, while the Plus model caters to patients needing additional stability and space.

  • How should the Oniris devices be stored before use, and what precautions should be taken to maintain their sterility?

    The Oniris and Oniris Plus are supplied in sterile packaging, meaning they should remain unopened until ready for use. Storage should follow the manufacturer’s guidelines to preserve sterility—typically in a clean, dry environment away from direct sunlight or extreme temperatures. Once opened, the device should be used immediately, as single-use devices are not intended for later use or reprocessing.

  • What regulatory pathways have the Oniris and Oniris Plus followed, and how does this affect their availability or approval status?

    The Oniris and Oniris Plus have been authorized through FDA 510K clearance and MDR (Medical Device Regulation) compliance, confirming they meet Class II medical device standards under the Dental specialty category. This regulatory route ensures they are classified as Anti-Snoring Devices (FDA code 872.5570) and are legally marketable in the U.S. and EU, though the exact availability depends on local regulatory approvals and distribution agreements.

Properties

Other properties (13)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No